Viewing nowCombinationAmoZaltan Q Tablet 5/50/10 mg (Amlodipine, Losartan, Rosuvastatin)
Amlodipine Camsylate 7.84mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201705685 · Approved 2017.07.14 · Insurance code 643507850
Treatment of hypertension; improvement of dyslipidemia; inhibition of atherosclerosis progression and reduction of cardiovascular disease risk
This medication is used for patients who need to take amlodipine/losartan combination therapy and rosuvastatin simultaneously. The amlodipine/losartan combination is effective when blood pressure control is not achieved adequately with monotherapy, and it is used as initial treatment for stage 2 hypertension patients. Rosuvastatin is used as an adjunctive treatment for patients with hypercholesterolemia and dyslipidemia when diet is ineffective, delaying the progression of atherosclerosis and helping reduce the risk of cardiovascular diseases. It particularly plays a role in reducing the risk of myocardial infarction, stroke, and vascular revascularization procedures. This medication effectively manages hypertension and hyperlipidemia to improve cardiovascular health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and rosuvastatin. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination in adults is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to the amlodipine/losartan combination may be considered as follows: - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before using the amlodipine/losartan combination as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, the target blood pressure, and the anticipated likelihood of achieving the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50mL/min); however, use of the amlodipine/losartan combination is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ∘ Patients with reduced effective intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older adults: For older adults aged 75 years or older, an initial losartan dose of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving rosuvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose in adults is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased to a maximum of 20 mg once daily. 2. Older adults: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Since systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. Patients taking amlodipine/losartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration.
This medication can have serious effects on the fetus and newborn, especially during pregnancy, and should be discontinued immediately if pregnancy is confirmed. Hypotension may occur in patients with reduced effective circulating blood volume, so their condition should be stabilized before administration, and specific dosage adjustments may be necessary. Patients with allergic reactions to any component of this medication or with certain diseases should not take it. Patients with severe liver or kidney impairment and those with certain muscle disorders should not use this medication. Elderly patients and those with hypotension, hyperkalemia, or mild to moderate liver impairment should use this medication cautiously, and patients with cardiac and vascular diseases also require careful monitoring. This medication can cause myalgia or myopathy and, rarely, severe muscle damage, so if muscle pain worsens or persists, medical attention should be sought immediately. During treatment, it is essential to check liver function and blood tests regularly to monitor for any abnormalities. When taken with other medications, interactions may enhance effects or increase the risk of side effects, so it is crucial to inform healthcare professionals about any currently taken medications. Breastfeeding women should also exercise caution, and women of childbearing age should use appropriate contraceptive methods. If any unusual symptoms such as dizziness, hypotensive symptoms, muscle pain, or breathing difficulties occur, consult a physician immediately.
Craniosynostosis, anuria, hypotension, renal failure, upper respiratory tract infection, dizziness, dyspepsia, lower gastrointestinal bleeding, orthostatic dizziness, syncope, rhabdomyolysis, pancreatic adenocarcinoma, dizziness, headache, drowsiness, cerebral infarction, asthenia, chest discomfort, chest pain, early satiety, peripheral edema, pituitary edema, abdominal discomfort, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, conjunctival injection, polyuria, angioedema, diabetes, constipation, nausea, abdominal pain, pancreatitis, rash, myalgia, myopathy, asthenia, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, ALT elevation, chest pain, myalgia, CK elevation, asthenia, joint pain, fatigue, numbness, dysesthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, fatigue, lassitude, pain, weight gain/loss, vasculitis, hypertonicity, sensory loss, peripheral neuropathy, dysgeusia, tremor, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, gastritis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, leukopenia, insomnia, mood changes, rhinitis, alopecia, hyperhidrosis, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased frequency of urination, urinary disorders, nocturia, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotensive crisis, sinoatrial block, atrioventricular block, precordial pain, diarrhea, loose stools, skin hyperemia, maculopapular rash, heaviness, warmth, impaired glucose tolerance, weakness, facial edema, fever, orthostatic effects, syncope, angina, second-degree atrioventricular block, cerebrovascular accident, hypotension, myocardial infarction, atrial fibrillation, palpitations, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, anorexia, toothache, dry mouth, flatulence, gastritis, vomiting, anemia, gout, upper extremity pain, hip pain, joint swelling, knee pain, muscle weakness, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory decrease, decreased libido, memory impairment, migraine, nervous hyperexcitability, panic disorder, sleep disorders, hypersomnia, tremor, dizziness, bronchitis, pharyngeal discomfort, epistaxis, rhinitis, respiratory congestion, chest discomfort, alopecia, dermatitis, dry skin, petechiae, erythema, flushing, photosensitivity reaction, itching, rash, sweating, urticaria, blurred vision, eye burning and pain, conjunctivitis, dysgeusia, tinnitus, decreased vision, erectile dysfunction, nocturia, polyuria, urethral infection, angioedema, vasculitis, anaphylactoid reaction syndrome, liver dysfunction, hepatitis, intestinal vascular edema, lassitude, anemia, thrombocytopenia, myalgia, asthenia, CK elevation, elevated serum and urinary myoglobin, dysgeusia, dry cough, erythroderma, hyperkalemia, hyponatremia, acute renal failure, oliguria, thrombocytopenia, elevated serum creatinine, ventricular ectopic beats, atrial fibrillation, hypoglycemia, asthenia, hunger, cold sweat, tremors, decreased concentration, seizures, altered consciousness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Additionally, avoid excessively hot or cold conditions, and store at room temperature between 1 and 30 degrees Celsius for safety.
White oval film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationAmlodipine Camsylate 7.84mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.